Loading…
EnteroMedics inked a collaborative deal with Galvani Bioelectronics, a joint venture between GlaxoSmithKline and Verily Life Sciences, under which Galvani will use a modified vBloc system for pre-clinical research. EnteroMedics will receive payments and retain IP ownership.